作者：
Aline Oliveira,da Silva de Barros [1]
;
Filipe Leal,Portilho [1]
;
Ana Paula,Dos Santos Matos [2]
;
Eduardo,Ricci-Junior [2]
;
Luciana Magalhães Rebêlo,Alencar [3]
;
Clenilton Costa,Dos Santos [3]
;
Francisco José Roma,Paumgartten [4]
;
Surtaj H,Iram [5]
;
Dominique,Mazier [6]
;
Jean-François,Franetich [6]
;
Frank,Alexis [7]
;
Ralph,Santos-Oliveira [8]
作者单位：
Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Novel Radiopharmaceuticals and Nano-radiopharmacy, Rio de Janeiro 21941906, Brazil.
[1]
Federal University of Rio de Janeiro, School of Pharmacy, Rio de Janeiro 21941901, Brazil.
[2]
Federal University of Maranhão, Laboratory of Biophysics and Nanosystems, São Luis do Maranhão 65080805, Brazil.
[3]
National School of Public Health, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21041361, Brazil.
[4]
Department of Chemistry and Biochemistry, College of Natural Sciences, South Dakota State University, Brookings, SD 57007, USA.
[5]
Sorbonne Université, INSERM, CNRS, INSERM U1135, Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Paris 75005, France.
[6]
School of Biological Sciences and Engineering, Yachay Tech University, Urcuquí 100119, Ecuador.
[7]
Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Novel Radiopharmaceuticals and Nano-radiopharmacy, Rio de Janeiro 21941906, Brazil; Zona Oeste State University, Laboratory of Nanoradiopharmaceuticals and Radiopharmacy, Rio de Janeiro 23070200, Brazil. Electronic address: roliveira@ien.gov.br.
[8]
DOI
10.1016/j.msec.2021.112275
PMID
34474834
发布时间
2021-09-06
换一批
换一批
